Menu ×

HEALTHCARE & PHARMACEUTICALDISCOUNT VALID TILL 31st-JANUARY , 2022

Oxycodone Market Segmentation by Route of Administration (Oral, Intravenous, and Others); by Application (Analgesic, Sedative, and Others); and by End-User (Hospitals, Oncological Centers, Drug Stores, and Others) – Global Demand Analysis & Opportunity Outlook 2030

  • Text Size:

Extensive insights into the Growth of Oxycodone Market amidst COVID-19

Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.

Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.

We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.

In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months.                                                         Request Insights

Read More

IN THE NEWS

·    January 14, 2021: Anesthetic and Analgesic Drug Products Advisory Committee, FDA, and the Drug Safety and Risk Management Advisory Committee to discuss the application of Oxycodegol, a new oxycodone-based drug, for the management of chronic lower back pain in adult patients.

·   March 24, 2021: FDA to establish an Opioid Systems Model, to overlook and highlight potential uses of opioid medications, misuse, and abuse.

Global Oxycodone Market Highlights over 2022 – 2030

The global oxycodone market is estimated to grow at a notable CAGR over the forecast period, i.e., 2022 – 2030. Oxycodone is a semisynthetic opioid, and has analgesic nature, similar to morphine. It is prescribed to cancer patients who experience extreme pain, owing to its analgesic and sedative properties. The growth of the market can be attributed to the growing prevalence of cancer, along with rising cancer mortality across the world. According to the data by the World Health Organization (WHO), over 10 million people died due to cancer in 2020, up from 9.6 million in 2018. Moreover, there were 2.26 million new cases of breast cancer, 2.21 million cases of lung cancer, and 1.41 million cases of prostate cancer in 2020 itself.

Moreover, the increasing cancer awareness, and rising demand for the development of new methods for treatment are estimated to propel the market growth. Along with this, growing investment in medical research activities is anticipated to boost the market growth. Furthermore, oxycodone is marketed as a combination narcotic, combined with either acetaminophen or aspirin, which reduces the abuse potential of the drug, which is also projected to fuel the market growth.

Oxycodone Market

The market is segmented by route of administration into oral, intravenous, and others, out of which, the oral segment is anticipated to hold the largest share in the global oxycodone market over the forecast period. This can be attributed to the safer action of oxycodone when taken orally, as it retains half of its analgesic properties when administered orally.  CLICK TO DOWNLOAD SAMPLE REPORT

Major Macro-Economic Indicators Impacting the Market Growth

Healthcare Expenditure

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Oxycodone Market Regional Synopsis

On the basis of geographical analysis, the global oxycodone market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in the Asia Pacific region is estimated to witness noteworthy growth, over the forecast period, on the back of large number of cancer patients in the region, along with the growing healthcare sector in the region.

The market in the North America region is anticipated to gain the largest market share throughout the forecast period owing to the rising cases of cancer in the region. According to the US National Cancer Institute, an estimated of 1,806,590 new cases of cancer were diagnosed in the United States in 2020. Moreover, the presence of major research institutes in the region, combined with high healthcare expenditure are estimated to boost the market growth.

Global Oxycodone Market

The global oxycodone market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Market Segmentation

Our in-depth analysis of the global oxycodone market includes the following segments:

By Route of Administration

  • Oral
  • Intravenous
  • Others

By Application

  • Analgesic
  • Sedative
  • Others

By End-User

  • Hospitals
  • Oncological Centers
  • Drug Stores
  • Others

Growth Drivers

  • Increasing Cases of Cancer Globally
  • Analgesic and Sedative Properties of Oxycodone

Challenges

  • Addictive Nature of Opioids
  • Lack of Enough Number of Researchers

Top Featured Companies Dominating the Market

  • Nektar Therapeutics
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Thermo Fisher Scientific Inc.
  • Boehringer Ingelheim GmbH
  • Bayer AG
  • Abbott Laboratories
  • Merck & Co., Inc.
  • Esteve Pharmaceuticals, S.A.
  • Validus Pharmaceuticals LLC
  • Teva Pharmaceutical Industries Ltd.
  • Siemens Healthcare GmbH

FREQUENTLY ASKED QUESTIONS


Related Reports


Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved